Experiences and reflections of doctors on the operations of designated clinics during the COVID-19 pandemic in Hong Kong: a qualitative study.

Publication date: Feb 11, 2025

The conversion of General Out-patient Clinics (GOPC) into COVID-19 designated clinics played a crucial role in combating COVID-19 pandemic in Hong Kong in 2022. This qualitative research aimed to contribute valuable perspectives from doctors on the operations of designated clinics for the preparedness of future outbreaks and health emergencies. This research adopted an interpretive phenomenological approach. Participants were purposively recruited from the doctors who worked in designated clinics during the COVID-19 pandemic in the Cluster of New Territories West, Hong Kong. Individual semi-structured interviews were conducted using an interview guide informed by the researchers’ past experiences and the Donabedian framework. The verbatim transcripts were imported into NVivo 12 for data organizing, coding and thematic analysis. Sixteen participants were recruited and interviewed until data sufficiency. Eight themes were elicited and grouped under the three domains of the Donabedian framework: structure (availability of facilities, supportive training and education, and flexible manpower allocation), process (challenges in clinical practices, communication and collaboration, and effectiveness of operations), and outcome (patient outcomes and impact to healthcare workers). Overall, participants thought that the operations in the designated clinics were smooth, efficient, and achieving satisfactory outcomes. However, improvements could be made in upgrading facilities to better manage more severe future outbreaks, enhancing government roles in information centralization and public communication and improving collaboration between designated clinics and ambulance services. This research provided valuable insights for the preparedness of future outbreaks and health emergencies.

Open Access PDF

Concepts Keywords
Doctors COVID-19
Interviews Pandemic preparedness
Pandemic Qualitative research
Recruited
Sixteen

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease IDO role
disease MESH emergencies
disease IDO process
drug DRUGBANK Tropicamide
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
drug DRUGBANK Cycloserine
disease MESH infection
disease MESH cross infections
disease MESH critically ill
disease MESH Severe Acute Respiratory Syndrome
disease MESH communicable diseases
drug DRUGBANK L-Phenylalanine
drug DRUGBANK Methionine
drug DRUGBANK Fenamole
disease MESH drug interactions
drug DRUGBANK Oxygen
disease MESH pneumonia
disease IDO site
disease IDO history
drug DRUGBANK Etoperidone
drug DRUGBANK Trestolone
drug DRUGBANK Hexocyclium
disease MESH upper respiratory tract infection
disease MESH common colds
disease MESH communication barriers
disease MESH complications
disease MESH chronic diseases
drug DRUGBANK Isoxaflutole
disease MESH dermatitis
disease MESH acne
disease MESH folliculitis
disease MESH inflammation
disease MESH psychological stress
drug DRUGBANK Spinosad
pathway REACTOME Influenza Infection
disease IDO pathogen
disease MESH burnout
drug DRUGBANK Esomeprazole
drug DRUGBANK Dihydrostreptomycin
drug DRUGBANK Etodolac
disease MESH cardiovascular disease

Original Article

(Visited 1 times, 1 visits today)